Animal models in type 2 diabetes research: an overview.

Department of Pharmacology & Toxicology, National Institute of Pharmaceutical Education & Research, Mohali, India.
The Indian Journal of Medical Research (Impact Factor: 1.66). 04/2007; 125(3):451-72.
Source: PubMed

ABSTRACT Type 2 diabetes is a complex and heterogeneous disorder presently affecting more than 100 million people worldwide and causing serious socio-economic problems. Appropriate experimental models are essential tools for understanding the pathogenesis, complications, and genetic or environmental influences that increase the risks of type 2 diabetes and testing of various therapeutic agents. The animal models of type 2 diabetes can be obtained either spontaneously or induced by chemicals or dietary or surgical manipulations and/or by combination thereof. In recent years, large number of new genetically modified animal models including transgenic, generalized knock-out and tissue-specific knockout mice have been engineered for the study of diabetes. This review gives an overview on the animal models of type 2 diabetes with reference to their origin/source, characteristic features, underlying causes/mechanism(s), advantages and disadvantages to the investigators in diabetes research. In addition, it especially describes the appropriate selection and usefulness of different animal models in preclinical testing of various new chemical entities (NCEs) for the treatment of type 2 diabetes.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Background: Diabetes mellitus type 1, formerly called insulin-dependent diabetes, is one of the autoimmune diseases where insulin-producing cells are destroyed by autoimmune response via T cells. The new approaches in treatment of diabetes are using the stem cells, cell transplantation of islet β cell, gene transfer by virus based plasmids, and non-viral gene constructs. Objectives: The purpose of this study was to construct glucose inducible insulin gene plasmid and use it in the muscle tissue of the rabbit. Materials and Methods: To achieve this goal, the preproinsulin, metallothionein2A promoter and the response element to carbohydrate genes were cloned into pBIND plasmid by standard cloning methods, to construct pBINDMTChIns. The gene cloning products were confirmed by the polymerase chain reaction (PCR) and restriction enzyme digestion template. The recombinant plasmid, containing the preproinsulin gene, was transferred into NIH3T3 cells and insulin gene expression was evaluated by reverse transcriptase PCR and western blotting techniques. Plasmid naked DNA containing the preproinsulin gene was injected into the rabbits' thigh muscles, and its expression was confirmed by western blotting method. Results: This study shows the prepared gene construct is inducible by glucose. Gene expression of preproinsulin was observed in muscle tissue of rabbits. Conclusions: These finding indicated that research in diabetes mellitus gene therapy could be performed on larger animals.
  • [Show abstract] [Hide abstract]
    ABSTRACT: The hypoglycemic and antioxidant effect of mung bean coat (MBC) in an animal model of type 2 diabetes was investigated. A 95% ethanol extract of MBC inhibited yeast α-glucosidase activity by 48.6% in vitro, which was 1.4× stronger than inhibition by acarbose at a concentration of 0.5 mg/mL. Five week old db/db mice were fed an AIN-93G diet or a diet containing the MBC extract at 1% for 7 weeks. Blood glycated hemoglobin and serum glucose levels, as well as the homeostasis model assessment for insulin resistance in MBC group mice, were significantly (p
    Food science and biotechnology 02/2013; 23(1):247-252. DOI:10.1007/s10068-014-0034-3 · 0.66 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Diabetes mellitus is major endocrine metabolic disorder of multiple etiologies characterized by chronic hyperglycemia; with disturbances of carbohydrate, protein and fat metabolism. Despite the introduction of hypoglycemic agents, diabetes and the related complications continue to be a major medical problem. Therefore, research for new antidiabetic drugs continues to be an area of concern. Streptozotocin induced diabetic model was used to evaluate oral antidiabetic activity of hydroalcoholic root extract of Croton macrostachys. Oral administration of the root extract of the plant did not exhibit toxicity at dose of 5 g/kg. The extract had hypoglycemic activity and improved glucose tolerance of the mice after acute oral glucose solution load. The extract had very significant antidiabetic activity compared to control groups in dose dependent manner. The highest dose, Croton macrostachys at 300 mg/kg produced antidiabetic activity comparable to the standard drug, Glibenclamide. Hydroalcoholic root extract of plant possess very significant antidiabetic activity. Hypoglycemic activity of the extract may be due to insulin mimetic or insulin secretagogue components present in the extract. It is recommended to further investigate the plant with solvent and bioguided fractionations to identify possible lead compounds for drug development.

Full-text (2 Sources)

Available from
May 15, 2014